Vaccination against M. tuberculosis – what next after BCG?
Journal Title: Advances in Hygiene and Experimental Medicine - Year 2011, Vol 65, Issue 0
Abstract
Tuberculosis (TB) still remains a huge global health problem. An increase in TB has been observed in many parts of the world, especially in poor and densely populated sub-Saharan Africa and Asia. Tuberculosis affects not only the developing countries but also the relatively wealthy regions of Europe, particularly Eastern Europe, where drug-resistant mycobacterial strains are increasingly reported. Control of tuberculosis expansion is very difficult. It requires the long-term use of anti-mycobacterial drugs. Additionally, the HIV epidemic and the phenomenon of multi-drug resistance are assumed to be responsible for the increase in TB cases. Therefore the most reasonable form of anti-TB protection seems to be effective vaccination. At the beginning of the twentieth century the BCG vaccine was introduced into general use as the first and so far the only immune protector against tuberculosis. Now it is known that this vaccine is not powerful enough and induces protection at a relatively low level. Hence ongoing research on the development of a more powerful anti-mycobacterial vaccine is still needed. Many of the new formulations are in phase II or III of clinical trials and the results are promising. The search for new vaccines involves several strategies: modified virulence-attenuated [i]Mycobacterium tuberculosis[/i] strains, recombination of attenuated M. bovis BCG bacilli, immunogenic mycobacterial proteins and DNA encoding selected proteins as well as unrelated microorganisms used as carriers of mycobacterial antigens. The wide range of concepts is extremely important because new vaccines should serve for immunization of the broadest possible population, not only healthy individuals but also those who are immunocompromised.
Authors and Affiliations
Marek Fol, Katarzyna Zawadzka, Magdalena Druszczyńska, Wiesława Rudnicka
Keywords
Related Articles
- EP ID EP66437
- DOI -
- Views 145
- Downloads 0
Rola przekaźnictwa glicynowego w patogenezie nadużywania alkoholu
Alcoholism is a severe social and medical problem. Inadequate ethanol (EtOH) consumption results in acute and chronic conditions, which lead to many hospitalizations and generate considerable costs in healthcare. Alcohol...
Karnityna: funkcja, metabolizm i znaczenie w niewydolności wątroby u pacjentów w przewlekłym zatruciu alkoholem
Alkoholizm jest jednym z najczęstszych uzależnień człowieka prowadzącym do wyniszczenia organizmu i śmierci. Chroniczne nadużywanie alkoholu zmniejsza utlenianie kwasów tłuszczowych przez zaburzenie metabolizmu karnityny...
DNA methylation in obesity
The number of overweight and obese people is increasing at an alarming rate, especially in the developed and developing countries. Obesity is a major risk factor for diabetes, cardiovascular disease, and cancer, and in c...
Facts and speculations on the infectious nature of Alzheimer’s disease
For over 30 years, a large volume of data has been collected indicating the possibility of an infectious form of Alzheimer’s disease (AD). Using various AD animal models and patients’ brain extracts it has been demonstra...
Autofagia w niedokrwieniu mózgu
Autofagia jest wewnątrzkomórkowym procesem degradacji makrocząsteczek i organelli komórkowych odgrywającym ważną rolę w utrzymaniu homeostazy oraz odpowiedzi na wiele bodźców uszkadzających. W ciągu ostatnich kilku lat p...